They demonstrated that levels of glutamine synthetase (an enzyme that protects neurons against excitotoxicity by facilitating glutamate uptake and conversion to glutamine) were significantly lower in patients with GBM and epilepsy than in those with nonepileptic GBM [25]. Here, GLUL is linked to glioblastoma.